Please try another search
CH Biotech R&D Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 824.81 million compared to TWD 800.85 million a year ago. Net income was TWD 419.07 million compared to TWD 392.85 million a year ago. Basic earnings per share from continuing operations was TWD 4.08 compared to TWD 4.05 a year ago. Diluted earnings per share from continuing operations was TWD 4.06 compared to TWD 3.96 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 143.73 | 110.94 | 459.31 | 800.85 |
Gross Profit | 109.71 | 87.13 | 384.25 | 679.01 |
Operating Income | -55.38 | -81.68 | 219.04 | 483.88 |
Net Income | -76.02 | -43.55 | 190.01 | 392.85 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 3649.21 | 3307.16 | 3394.27 | 3601.59 |
Total Liabilities | 1129.06 | 1139.08 | 1095.91 | 1500.14 |
Total Equity | 2520.15 | 2168.08 | 2298.36 | 2101.45 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -89.8 | 79.03 | 457.88 | 212.04 |
Cash From Investing Activities | -51.71 | -44.7 | -20.76 | -25.72 |
Cash From Financing Activities | 398.41 | -56.53 | -412.82 | -35.66 |
Net Change in Cash | 255.66 | -21.68 | 25.45 | 150.47 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review